488 related articles for article (PubMed ID: 2168288)
1. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
2. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
3. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
4. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines.
Lan MS; Russell EK; Lu J; Johnson BE; Notkins AL
Cancer Res; 1993 Sep; 53(18):4169-71. PubMed ID: 8364910
[TBL] [Abstract][Full Text] [Related]
5. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
Poola I; Graziano SL
J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
9. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
10. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Vyberg M; Horn T; Francis D; Askaa J
Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
[TBL] [Abstract][Full Text] [Related]
12. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
[TBL] [Abstract][Full Text] [Related]
14. Effects of dibutyryl cyclic adenosine 3':5'-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of L-dopa decarboxylase.
Francis J; Thompson R; Bernal SD; Luk GD; Baylin SB
Cancer Res; 1983 Feb; 43(2):639-45. PubMed ID: 6293702
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
16. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF
Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
18. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
19. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
20. [Molecules of regulated secretion are differentiation markers of neuroendocrine tumors].
Schmitt-Gräff A; Müller H; Rancso C; Ahnert-Hilger G; John M; Riecken EO; Stein H; Wiedenmann B
Verh Dtsch Ges Pathol; 1997; 81():157-61. PubMed ID: 9474867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
